X4 Share Price

X4 Share Price

NASDAQ: XFOR | Micro Cap | Healthcare
$3.01
+$0.06 (2.03%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

X4 Stock Performance

Open
$2.93
Prev. Close
$2.95
Circuit Range
N/A
Day Range
$2.90 - $3.04
Year Range
$2.44 - $4.82
Volume
98,655
Average Traded
$2.98

X4 Share Price Today

As of 22 November 2026, X4 Pharmaceuticals, Inc.'s share price is $3.01. The stock opened at $2.93, compared to its previous close of $2.95. During today's trading session, X4 Pharmaceuticals, Inc.'s share price traded between $2.90 and $3.04, with an average price of $2.97. Over the past 52 weeks, the stock has recorded a high of $4.82 and a low of $2.44. In terms of performance, X4 Pharmaceuticals, Inc.'s share price has declined by 30.08% over the last six months and is down 17.53% on a year-on-year basis.

X4 Share Price Chart

Line chart of the X4 price trend over the selected period. The price rose overall, ranging from 2.90 to 3.07, ending at 3.01.
$2.90$3.04
L
Show Current Price
H

X4 Stock Fundamentals & Key Indicators

Market Cap
$127.30M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.79
Revenue (TTM)
$35.11B
Return On Equity (TTM)
-57.98%
Profit Margin
-225.58%
Debt to Equity
0.55
Quarterly Earnings Growth YoY
15.59%

X4 Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$2.57$2.71$8.81$2.88
Net Profit-$23.93-$20.24-$16.16-$20.20
Net Profit Margin-931.13%-746.86%-183.43%-701.39%
Income ChangeN/A15.42%20.16%-25.00%

X4 Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$2.56$35.11
Net Profit-$96.41-$101.17-$37.45-$79.20
Net Profit MarginN/AN/A-1462.89%-225.58%
Income ChangeN/A-4.94%62.98%-111.48%

X4 Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets28.8834.2725.1826.91
Current Assets261.58112.18122.08128.68
Total Assets290.46146.45147.26155.59
Non Current Liabilities78.4191.4273.359.21
Current Liabilities25.7632.8822.8622.32
Total Liabilities104.17124.396.1681.54
Shareholders' Equity186.2922.1551.174.05

X4 Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-85.62-130.9-96.51-77.1
Investing8.1566.99-14.88-0.1
Financing238.6320.2988.52117.23

Corporate Actions

Split
Ex-date: 28 Apr 2025

About X4

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

X4 Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.37
$3.00
-10.16%
Oct 2026
$2.87
$3.35
+15.15%
Sep 2026
$4.04
$2.90
-31.24%
Aug 2026
$4.00
$4.22
+6.42%
Jul 2026
$4.63
$3.97
-14.90%
Jun 2026
$4.20
$4.67
+8.36%
May 2026
$4.07
$4.30
+5.51%
Apr 2026
$4.23
$4.08
-0.97%
Mar 2026
$3.31
$4.12
+20.12%
Feb 2026
$3.67
$3.43
-7.30%
Jan 2026
$3.91
$3.70
-7.82%
Dec 2025
$3.58
$4.01
+9.97%

X4 Share Price FAQs